Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-044185
Filing Date
2025-05-15
Accepted
2025-05-15 16:05:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 18091
2 JOINT FILING AGREEMENT ea024213101ex99-1_biomx.htm EX-99.1 13764
  Complete submission text file 0001213900-25-044185.txt   33681
Mailing Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST. FLOOR 4 NESS ZIONA L3 7414003 972 723942377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90744 | Film No.: 25952644
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O GENEVA TRUST COMPANY (GTC) SA RUE DE L'ATHENEE 34 GENEVA V8 1206
Business Address P.O. BOX 3162 WOODBOURNE HALL ROAD TOWN TORTOLA D8 VG1110 41 22 789 1200
Centaurus Investments Ltd (Filed by) CIK: 0001993498 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0531
Type: SCHEDULE 13G